NeuralNet Biotech uses computational biology and machine learning to analyze complex biological data, accelerating the discovery and optimization of biological processes. Our platform identifies predictive biomarkers and designs novel biotechnological solutions, de-risking early-stage research for drug discovery and bioprocess development.
Funding
Funding not disclosed
Founders
Product
Problem
The life sciences sector faces challenges in translating complex biological data into actionable insights for product development. This often leads to extended R&D cycles and difficulties in identifying optimal therapeutic targets or process parameters.
Solution
NeuralNet Biotech leverages advanced computational biology and machine learning to accelerate the discovery and optimization of biological processes. Our platform analyzes large-scale omics data and experimental results to identify predictive biomarkers and design novel biotechnological solutions. We provide a data-driven approach to de-risk early-stage research and streamline the development pipeline for new therapeutics and industrial bioprocesses.
Target Audience
Our primary customers are pharmaceutical companies, biotechnology firms, and academic research institutions engaged in drug discovery and bioprocess development.
Features
- Proprietary algorithms for multi-omics data integration and analysis
- Machine learning models for predictive target identification and validation
- Simulation engine for optimizing bioprocess parameters and yield
- Workflow automation for experimental design and data management
- Cloud-based platform for secure data storage and collaborative research